POSA130 Events Avoided and Cost Savings Associated with Ferric Carboxymaltose Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction from the Perspective of Healthcare Payers in Switzerland
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.273
https://www.valueinhealthjournal.com/article/S1098-3015(21)02068-4/fulltext
Title :
POSA130 Events Avoided and Cost Savings Associated with Ferric Carboxymaltose Treatment of Iron Deficiency in Patients with Acute Heart Failure with Reduced Ejection Fraction from the Perspective of Healthcare Payers in Switzerland
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02068-4&doi=10.1016/j.jval.2021.11.273
First page :
Section Title :
Open access? :
No
Section Order :
11045